Key terms
About KRYS
Krystal Biotech, Inc. engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest KRYS news
Apr 16
6:50am ET
Krystal Biotech price target raised to $204 from $178 at Stifel
Feb 29
10:57am ET
Biotech Alert: Searches spiking for these stocks today
Feb 29
10:57am ET
Biotech Alert: Searches spiking for these stocks today
Feb 28
11:59am ET
Biotech Alert: Searches spiking for these stocks today
Feb 28
11:59am ET
Biotech Alert: Searches spiking for these stocks today
Feb 27
9:24am ET
Krystal Biotech price target raised to $168 from $140 at BofA
Feb 27
8:37am ET
Krystal Biotech price target raised to $175 from $130 at Guggenheim
Feb 27
7:24am ET
Krystal Biotech price target raised to $208 from $160 at TD Cowen
Feb 27
6:51am ET
Krystal Biotech price target raised to $195 from $160 at Citi
Feb 27
6:07am ET
Krystal Biotech price target raised to $200 from $139 at H.C. Wainwright
Feb 27
6:02am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), Krystal Biotech (KRYS) and Bristol-Myers Squibb (BMY)
Feb 27
1:02am ET
New Sales & Marketing Risk for Krystal Biotech, Inc. – What’s the Latest?
Feb 26
8:35pm ET
Buy Rating for Krystal Biotech Amidst Strong Vyjuvek Sales and Sizable Market Opportunity
Feb 26
8:06am ET
Krystal Biotech sees 2024 non-GAAP R&D, SG&A expense $150M-$175M
Feb 26
8:05am ET
Krystal Biotech reports Q4 EPS 30c, consensus (38c)
Feb 08
7:06am ET
Krystal Biotech announces publication in NEJM on application of B-VEC
Feb 02
8:11am ET
Krystal Biotech added to ‘Tactical Outperform’ list at Evercore ISI
Jan 25
7:26am ET
Stifel Nicolaus Keeps Their Buy Rating on Krystal Biotech (KRYS)
No recent press releases are available for KRYS
KRYS Financials
Key terms
Ad Feedback
KRYS Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
KRYS Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range